|
C3ORF17 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.278600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.950200E-02 |
| Normal-vs-Stage2 |
8.853200E-01 |
| Normal-vs-Stage3 |
1.602620E-01 |
| Normal-vs-Stage4 |
3.235400E-01 |
| Stage1-vs-Stage2 |
2.576600E-01 |
| Stage1-vs-Stage3 |
8.619600E-01 |
| Stage1-vs-Stage4 |
7.690000E-01 |
| Stage2-vs-Stage3 |
3.142400E-01 |
| Stage2-vs-Stage4 |
4.071800E-01 |
| Stage3-vs-Stage4 |
8.641600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.069200E-01 |
| Normal-vs-AfricanAmerican |
5.030800E-01 |
| Normal-vs-Asian |
3.127600E-01 |
| Caucasian-vs-AfricanAmerican |
8.316600E-01 |
| Caucasian-vs-Asian |
8.376800E-01 |
| AfricanAmerican-vs-Asian |
7.845200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.392400E-02 |
| Normal-vs-Female |
7.486200E-01 |
| Male-vs-Female |
9.070100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.595160E-01 |
| Normal-vs-Extreme_Weight |
3.976100E-02 |
| Normal-vs-Obese |
5.251000E-01 |
| Normal-vs-Extreme_Obese |
2.726800E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.954400E-01 |
| Normal_Weight-vs-Obese |
4.131800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.658600E-01 |
| Extreme_Weight-vs-Obese |
2.521600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.957400E-01 |
| Obese-vs-Extreme_Obese |
4.027200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.909800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.467000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.369900E-02 |
| Normal-vs-Age(81-100Yrs) |
7.097100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.777800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.407800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.394440E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.120200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.531610E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.749240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.803600E-01 |
| Normal-VS-Type2 PRCC |
2.324500E-03 |
| Normal-VS-KIRP CIMP |
9.013900E-02 |
| Normal-VS-Unclassified PRCC |
8.160800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.503020E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.224620E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.058400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.576400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.785600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.856200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.388500E-04 |
| Normal-vs-N1 |
4.482000E-01 |
| Normal-vs-N2 |
3.87870000000401E-05 |
| N0-vs-N1 |
1.537980E-02 |
| N0-vs-N2 |
1.190360E-01 |
| N1-vs-N2 |
3.659900E-02 |
|
|
